Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Betting On Enstar Group Ltd. (ESGR)

Page 1 of 2

Enstar Group Ltd. (NASDAQ:ESGR) was in 8 hedge funds’ portfolio at the end of the first quarter of 2013. ESGR has experienced an increase in support from the world’s most elite money managers lately. There were 6 hedge funds in our database with ESGR positions at the end of the previous quarter.

In the financial world, there are tons of indicators shareholders can use to watch the equity markets. A duo of the most innovative are hedge fund and insider trading sentiment. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the top money managers can trounce their index-focused peers by a significant amount (see just how much).

Enstar Group Ltd. (NASDAQ:ESGR)

Equally as important, bullish insider trading activity is another way to break down the investments you’re interested in. Obviously, there are a variety of reasons for an executive to drop shares of his or her company, but just one, very obvious reason why they would behave bullishly. Many empirical studies have demonstrated the valuable potential of this strategy if “monkeys” understand where to look (learn more here).

Consequently, let’s take a peek at the recent action surrounding Enstar Group Ltd. (NASDAQ:ESGR).

How have hedgies been trading Enstar Group Ltd. (NASDAQ:ESGR)?

At Q1’s end, a total of 8 of the hedge funds we track were bullish in this stock, a change of 33% from the previous quarter. With hedge funds’ sentiment swirling, there exists a few noteworthy hedge fund managers who were increasing their stakes significantly.

According to our comprehensive database, Akre Capital Management, managed by Charles Akre, holds the most valuable position in Enstar Group Ltd. (NASDAQ:ESGR). Akre Capital Management has a $62.6 million position in the stock, comprising 3.5% of its 13F portfolio. Sitting at the No. 2 spot is Chuck Royce of Royce & Associates, with a $15 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Some other peers that hold long positions include Jim Simons’s Renaissance Technologies, Ken Griffin’s Citadel Investment Group and Cliff Asness’s AQR Capital Management.

As industrywide interest jumped, some big names were leading the bulls’ herd. Citadel Investment Group, managed by Ken Griffin, assembled the most outsized position in Enstar Group Ltd. (NASDAQ:ESGR). Citadel Investment Group had 0.5 million invested in the company at the end of the quarter. Cliff Asness’s AQR Capital Management also made a $0.5 million investment in the stock during the quarter. The other funds with brand new ESGR positions are Mike Vranos’s Ellington and Israel Englander’s Millennium Management.

What have insiders been doing with Enstar Group Ltd. (NASDAQ:ESGR)?

Insider buying is particularly usable when the company in focus has experienced transactions within the past six months. Over the last half-year time frame, Enstar Group Ltd. (NASDAQ:ESGR) has seen 1 unique insiders buying, and 3 insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to Enstar Group Ltd. (NASDAQ:ESGR). These stocks are Kemper Corporation (NYSE:KMPR), The Hanover Insurance Group, Inc. (NYSE:THG), MBIA Inc. (NYSE:MBI), Mercury General Corporation (NYSE:MCY), and Endurance Specialty Holdings Ltd. (NYSE:ENH). This group of stocks belong to the property & casualty insurance industry and their market caps resemble ESGR’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!